- Home
- NBY vs CBRE Comparison
NBY vs CBRE Comparison
Compare NBY & CBRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBY
- CBRE
- Stock Information
- Founded
- NBY 2000
- CBRE 1906
- Country
- NBY United States
- CBRE United States
- Employees
- NBY N/A
- CBRE N/A
- Industry
- NBY
- CBRE Real Estate
- Sector
- NBY
- CBRE Finance
- Exchange
- NBY Nasdaq
- CBRE Nasdaq
- Market Cap
- NBY 3.5M
- CBRE N/A
- IPO Year
- NBY 2007
- CBRE 2004
- Fundamental
- Price
- NBY $0.61
- CBRE $122.85
- Analyst Decision
- NBY
- CBRE Buy
- Analyst Count
- NBY 0
- CBRE 6
- Target Price
- NBY N/A
- CBRE $113.83
- AVG Volume (30 Days)
- NBY 7.7M
- CBRE 1.5M
- Earning Date
- NBY 11-07-2024
- CBRE 10-24-2024
- Dividend Yield
- NBY N/A
- CBRE N/A
- EPS Growth
- NBY N/A
- CBRE 12.59
- EPS
- NBY N/A
- CBRE 2.98
- Revenue
- NBY $13,884,000.00
- CBRE $33,144,000,000.00
- Revenue This Year
- NBY N/A
- CBRE $13.24
- Revenue Next Year
- NBY $26.04
- CBRE $10.36
- P/E Ratio
- NBY N/A
- CBRE $41.18
- Revenue Growth
- NBY 4.06
- CBRE 7.42
- 52 Week Low
- NBY $0.36
- CBRE $64.63
- 52 Week High
- NBY $14.00
- CBRE $125.43
- Technical
- Relative Strength Index (RSI)
- NBY 43.56
- CBRE 58.85
- Support Level
- NBY $0.60
- CBRE $119.05
- Resistance Level
- NBY $0.70
- CBRE $121.93
- Average True Range (ATR)
- NBY 0.04
- CBRE 2.10
- MACD
- NBY -0.01
- CBRE -0.45
- Stochastic Oscillator
- NBY 4.67
- CBRE 64.12
About NBY NovaBay Pharmaceuticals Inc.
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically eyecare and skincare products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease. It has two reportable segments: Eyecare and Wound Care and Skincare.